The project, titled "To Identify Metabolic Biomarkers for Microbiome for Early Detection of a) Type-2 Diabetes (T2D), b) Obesity, c) Stress (Anxiety and Depression, SAD), and d) Neurodegenerative Diseases (NDD) & Longitudinal Study of Impact of Probiotics," focused on exploring the microbiome and metabolome profiles of patients to predict the metabolites as the biomarker of microbiome and disease.

As the Senior Research Scientist in Research and Development (R&D), I supervise preclinical and clinical studies for both underdeveloped and newly developed products, conducted in-house as well as at third-party laboratories, across both domestic and international locations. My portfolio includes a selection of notable studies, such as:• Clinical studies on axillary hyperpigmentation• Studies on under-eye dark circles and puffiness• Scalp sebum reduction studies• Human Repeat Insult Patch Testing (HRIPT)• Seal of acceptance studies from the National Eczema Association• SPF and PA testing• Development of cell-culture labs for microbial and mammalian cultures• Anti-acne, Anti-dandruff , USP-51• And others